JUVA

COM:JUVALIFE

Juva Life

  • Stock

CAD

Last Close

0.03

12/07 13:30

Market Cap

2.63M

Beta: -

Company Overview

Metric
Company NameJuva Life Inc.Migraine Buddy
SymbolJUVA
MSH IDCOM:JUVALIFECOM:MIGRAINEBUDDY
MarketSTOCKSPRIVATE
SectorHealthcareHealthcare & Health Services
IndustryDrug Manufacturers - Specialty & GenericHealth Technology
CountryCAUS
StageDebt
Employee Count
Websitejuvalife.commigrainebuddy.com
LinkedInjuvalifemigrainebuddyapp
Founders

Market Metrics

Metric
Market Cap1.86M
Enterprise Value
Monthly Web Traffic1.46K81.88K
Web Traffic Growth4.400.31
Valuation
Raised Capital11.80M

Financial Performance

Metric
Revenue5.76M
Revenue (LTM)
Revenue (NTM)
Gross Profit43.97K
EBITDA-7.98M
Operating Income-8.94M
Net Income-10.48M
EPS-0.06
Diluted EPS-0.06
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.28
Operating Profit Margin-0.40
EBITDA Margin-1.38
Net Profit Margin-0.65
Return on Equity-0.65
Return on Assets-0.22
Return on Capital Employed-0.17

Valuation Multiples

Metric
P/E Ratio-0.69
P/B Ratio0.36
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio1.75
EV Multiple5.17

Operational Metrics

Metric
Days Sales Outstanding52.20
Days Payables Outstanding441.34
Days Inventory Outstanding68.96
Operating Cycle78.62
Cash Conversion Cycle-57.28
Asset Turnover0.42

Cash Flow Metrics

Metric
Operating Cash Flow-7.33M
Free Cash Flow-12.66M
Cash Flow to Debt-0.18
Operating Cash Flow/Sales-0.30
Free Cash Flow Yield-1.00

Balance Sheet Metrics

Metric
Cash & Equivalents641.04K
Accounts Receivable-112.21K
Inventory357.40K
Goodwill
Debt to Capitalization0.69
Debt to Assets0.42
Current Ratio0.78
Quick Ratio0.47

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.14
R&D to Revenue0.04
SG&A to Revenue1.03